Aditxt, Inc. Merger with Evofem Biosciences Falls Through
Company Announcements

Aditxt, Inc. Merger with Evofem Biosciences Falls Through

Aditxt, Inc. (ADTX) has issued an announcement.

Aditxt, Inc. had previously announced its plans to merge with Evofem Biosciences, Inc., with the latter set to become a subsidiary of Aditxt. However, due to Aditxt’s inability to deliver the initial equity investment required, Evofem has exercised its right to terminate the merger agreement effective immediately, disrupting the anticipated consolidation within the industry.

For detailed information about ADTX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAditxt announces Evofem secures voting agreements with investors for merger
TipRanks Auto-Generated NewsdeskAditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
TheFlyAditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App